CDH3 Gene Ectodermal Dysplasia Ectrodactyly and Macular Dystrophy Genetic Test sale cost 4400 AED
GUCY2C Gene Diarrhea Type 6 Genetic Test sale cost 4400 AED GUCY2C Gene Diarrhea Type 6 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
FKBP14 Gene Ehlers-Danlos Syndrome with Progressive Kyphoscoliosis Myopathy and Hearing Loss Genetic Test sale cost 4400 AED FKBP14 Gene Ehlers-Danlos Syndrome with Progressive Kyphoscoliosis Myopathy and Hearing Loss Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CDH3 Gene Ectodermal Dysplasia Ectrodactyly and Macular Dystrophy Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CDH3 Gene Ectodermal Dysplasia, Ectrodactyly, and Macular Dystrophy Genetic Test” is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the CDH3 gene. These mutations are known to cause a rare genetic disorder characterized by a combination of ectodermal dysplasia (abnormal development of the skin, hair, nails, teeth, or sweat glands), ectrodactyly (a condition where part of one or more limbs is absent), and macular dystrophy (a condition that affects the central part of the retina, leading to vision loss). The test, which costs 4400 AED, is crucial for accurate diagnosis, allowing for tailored treatment plans and genetic counseling for affected individuals and their families. This genetic test involves analyzing the patient’s DNA to identify any alterations in the CDH3 gene, which plays a significant role in cell-cell adhesion and signaling critical for proper ectodermal development and function.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CDH3 Gene Ectodermal Dysplasia Ectrodactyly and Macular Dystrophy Genetic Test

Test Name: CDH3 Gene Ectodermal dysplasia ectrodactyly and macular dystrophy Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CDH3 Gene Ectodermal dysplasia, ectrodactyly, and macular dystrophy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDH3 Gene Ectodermal dysplasia, ectrodactyly, and macular dystrophy NGS Genetic DNA Test gene CDH3

Test Details

The CDH3 gene is associated with a condition called ectodermal dysplasia, ectrodactyly, and macular dystrophy (EEM) syndrome. This genetic test, known as NGS (Next-Generation Sequencing), is used to analyze the DNA sequence of the CDH3 gene to identify any mutations or variations that may be causing the EEM syndrome.

Ectodermal dysplasia refers to a group of genetic disorders that primarily affect the development of the ectodermal tissues, which include the skin, hair, nails, teeth, and sweat glands. Ectrodactyly, also known as split hand/foot malformation, is a condition characterized by missing or underdeveloped fingers or toes. Macular dystrophy is a progressive eye disorder that affects the macula, the central part of the retina responsible for sharp, central vision.

By performing an NGS genetic test on the CDH3 gene, healthcare professionals can identify specific mutations or variations in the gene that are associated with EEM syndrome. This information can help in diagnosing individuals with EEM syndrome, providing genetic counseling to affected individuals and their families, and potentially guiding treatment options or interventions.

Test Name CDH3 Gene Ectodermal dysplasia ectrodactyly and macular dystrophy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CDH3 Gene Ectodermal dysplasia, ectrodactyly, and macular dystrophy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDH3 Gene Ectodermal dysplasia, ectrodactyly, and macular dystrophy NGS Genetic DNA Test gene CDH3
Test Details

The CDH3 gene is associated with a condition called ectodermal dysplasia, ectrodactyly, and macular dystrophy (EEM) syndrome. This genetic test, known as NGS (Next-Generation Sequencing), is used to analyze the DNA sequence of the CDH3 gene to identify any mutations or variations that may be causing the EEM syndrome.

Ectodermal dysplasia refers to a group of genetic disorders that primarily affect the development of the ectodermal tissues, which include the skin, hair, nails, teeth, and sweat glands. Ectrodactyly, also known as split hand/foot malformation, is a condition characterized by missing or underdeveloped fingers or toes. Macular dystrophy is a progressive eye disorder that affects the macula, the central part of the retina responsible for sharp, central vision.

By performing an NGS genetic test on the CDH3 gene, healthcare professionals can identify specific mutations or variations in the gene that are associated with EEM syndrome. This information can help in diagnosing individuals with EEM syndrome, providing genetic counseling to affected individuals and their families, and potentially guiding treatment options or interventions.

SKU: TEST-2934 Category:

Related products